Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
about
NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesMolecular biology of lung cancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsIs the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategiesNotch Signaling in Neuroendocrine TumorsEpigenetic modulators, modifiers and mediators in cancer aetiology and progressionTargeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsCancer stem cells in small cell lung cancerCellular and molecular biology of small cell lung cancer: an overviewNovel therapies in small cell lung cancerScientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in CancerDifferences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationOrigins, genetic landscape, and emerging therapies of small cell lung cancerMediator kinase module and human tumorigenesisPredictive biomarkers in precision medicine and drug development against lung cancerTransformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originGenomic profiling of small-cell lung cancer: the era of targeted therapiesMutational signatures: the patterns of somatic mutations hidden in cancer genomesCancer stem cell division: when the rules of asymmetry are brokenFunctional genomics lead to new therapies in follicular lymphomaGenomic sequencing in cancerGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsFrom fly wings to targeted cancer therapies: a centennial for notch signalingHijacked in cancer: the KMT2 (MLL) family of methyltransferasesTargeted therapies in development for non-small cell lung cancerActivation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung CancerFibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersControl of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetPersonalized treatment of advanced non-small-cell lung cancer in routine clinical practiceAcetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and CancerNew and emerging developments in extensive-stage small cell lung cancer therapeuticsCheckpoint inhibitors in lung cancer: latest developments and clinical potentialHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsImmune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?Biology of MET: a double life between normal tissue repair and tumor progression
P2860
Q24596715-A1A12002-49A9-4264-B660-3B1FB7891F5BQ24606677-76C9CED5-2B97-4CEF-BE36-5FDD7A5016CFQ26741318-86C4E161-4DDA-4248-BEDF-2729D900C25BQ26748741-20B097FE-2C81-43F1-9F46-4E5DF2182691Q26750380-98CA108E-1B7B-466F-A271-10F73B7B6619Q26752380-1E0AC708-D7C6-433D-BA84-822786B4FF54Q26766149-06F94214-0408-4379-BF19-F7CEB8CFA955Q26767017-864E561F-2A92-44D5-8019-2718EAFC6E42Q26767020-D8DAD31E-FFC4-4E3C-95B7-4D55FFFAF216Q26767026-724EE96C-28A8-4ACA-89A9-5E93E2A12E74Q26767029-F8B78CF0-EFAC-4322-BBC9-AF0563739D94Q26775390-8DD9A1F3-80A5-44BD-BEF7-4EAC5575FB19Q26784060-BD8EB5B6-A757-4F15-BC38-CA2856ABCE5FQ26786594-988F3163-0FE9-4129-BBAA-B98899E40CA5Q26798218-3F4C489C-B79B-41B8-9FB5-25808B7D7808Q26800203-F23E8675-4202-42CC-9065-BF3A09D6DF9CQ26824536-29DFE8CD-E544-45F4-8558-32B39C188BC6Q26826437-AA285ECF-C5B2-4E6E-9326-41982DC77E4AQ26826915-89DC878C-AA12-4AF3-9A9D-8CC89B2A1CC4Q26850125-7A3985D4-0A4F-4457-9B1C-1930CD70DADDQ26851679-66A3CD59-4A44-4ED5-9697-D89028EFC9B0Q26852415-A56655BD-EFC0-4702-9664-22120ECB7D6BQ26853507-82B2F929-6BD5-41DF-B87E-1A097C140D53Q26998790-3BAED2CB-EB55-461F-91C1-19F00487E13DQ27004534-C0C27A55-0D45-408C-B1D5-B77111A4EA65Q27006839-6E5CB858-3127-4DFC-A451-27C70F69FD0DQ27022852-96779211-10CB-4D22-BBD1-8701B960B66AQ27315948-98081956-A75E-4C36-AF43-5D94A92D7DC0Q27852581-A7281479-1DE6-42E7-8350-B347A0060AA8Q27852601-FCB8B635-2BFC-401A-B954-97CC4A52DCE3Q27852999-F7172730-04AC-439F-A625-6A2FFBBB53A0Q27853171-FDCDF62D-1A47-4EAB-B5F3-848C2D8652B3Q28070887-9F9A8EC1-EE2C-4B16-8FA1-019416C387DEQ28075800-DE5F9FE5-D071-4255-993A-7114825C7C48Q28076086-0FD760AE-809B-4060-8D9C-8338A405BB2CQ28076304-05A1313A-5164-463B-B2C5-5A21D341749FQ28076467-6CB310F1-AC67-4568-8107-460C67AF2E1EQ28077504-CCA24BC9-229A-4B21-BBB2-2364A724BC09Q28079771-5AB4EB55-F122-4785-87D6-8E5538E89A77Q28085247-F36E68F3-012B-4867-86E5-0F5C1337C68E
P2860
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Integrative genome analyses id ...... ions of small-cell lung cancer
@en
type
label
Integrative genome analyses id ...... ions of small-cell lung cancer
@en
prefLabel
Integrative genome analyses id ...... ions of small-cell lung cancer
@en
P2093
P2860
P50
P356
P1433
P1476
Integrative genome analyses id ...... ions of small-cell lung cancer
@en
P2093
Alex Soltermann
Benjamin Besse
Benjamin Solomon
Christian Becker
Christian Brambilla
Christian Grütter
Christian Müller
Claudia Ligorio
Corinna Ludwig
Daniëlle A M Heideman
P2860
P2888
P304
P356
10.1038/NG.2396
P407
P50
P577
2012-09-02T00:00:00Z